Leafly News’ experts accurately predicted weed news 74% of the time in 2022. Watch out, 2023!
Cannabis strain predictions
It’s going to be the year of Rainbow Sherbert 11 and crosses, which is third and fourth-generation Zkittlez work. The Rootbeer strain is going to take off. Same with Trop Cherry and Super Boof. GastroPop, as well as strains bred from the Y line are going to pop.
The seed-selling industry will go even crazier, now that the DEA said anything under 0.3% THC is just hemp; like birdseed. Everyone is gonna have a seed brand. The cannabis genetics golden era brightens further.
We’re going to get proof that some terpenes—aroma molecules in weed—create outsized smell and effects relative to their amounts. We’ll also learn about previously unclassified or unnamed molecules contributing to aroma and effect.
Solventless “Live rosin” is about to have an even bigger year.
Weed lifestyle trends
We anticipate hundreds of new dispensaries will open across dozens of new cities. Delivery services will spread.
Las Vegas will leap to the forefront of the cannabis consumption lounge trend. New state-licensed lounges will open in Sin City, many with the over-the-top design and luxury amenities we’ve come to expect from America’s adult playground.
At least one of the new lounges will partner with a rideshare company to return patrons safely home (or, let’s be honest, to their hotels on the Strip).
A mushroom backlash will begin after a high-profile incident amid the wave of charlatans exploiting the hype. New research papers on why shrooms help will come out. New papers on why shrooms may hurt will come out.
New cities will legalize/decriminalize psychedelics. Other cities/legislatures will stiffen penalties for psychedelics.
Ketamine therapy will continue to go more mainstream and begin to jump the shark.
CBD, delta-8 and beyond
Cannabidiol science will advance—with new discoveries around medical effects, or lack thereof.
New studies will find some unhealthy compounds and effects in novel cannabinoid products like THC-O.
New states are going to crack down on designer cannabinoids like delta-8-thc, hemp-derived d-9-thc, THC-O, HHC, etc.
Cannabis industry predictions
Pot prices will not soften in Illinois. A government-throttled legal supply will not meet demand. Pot prices will continue to fall in Michigan. Supply appears to exceed demand there.
Oklahoma medical marijuana enforcement will ramp up. Unbridled medical marijuana cultivation has drawn a backlash. Oregon illicit market enforcement will kick in. Illicit suppliers there flooded the legal market in 2022.
The world’s biggest legal cannabis market, Los Angeles, will remain stalled with no meaningful increase in brick-and-mortar outlets, and more equity lawsuits. California will not bring its illicit market under control. As a result, California prices will remain low.
New York is going to have a rough first year of legal, licensed sales: Expect high prices, few stores, more lawsuits, dirty street weed, and continuing crackdowns on unlicensed sellers. A heavy-handed government roll-out means demand far exceeds legal supply at few stores. An untested illicit market meets the rest of demand, and that spurs enforcement.
Cannabis stocks will remain depressed. High inflation has moderated cannabis sales, and triggered high federal interest rates, which depresses stocks. Also depressing equities—no movement on legalization in Congress (see below).
Other states will follow California’s lead and create organic labels, like California’s OCal program—”a statewide certification program that establishes and enforces comparable-to-organic cannabis standards.”
More celebrity brands will launch. We’ll see the first big celeb brand go bust.
More aggrieved parties like Variscite NY One, Inc. will challenge equity programs in court. The federal lawsuit that’s currently holding up dozens of equity licenses in New York may set a chilling precedent.
New cases of lung injuries from tainted THC vape cartridges may come to light, most likely a limited EVALI outbreak in a prohibition state. The hemp-derived THC loophole has opened up major sales and marketing opportunities for vape cartridge manufacturers, without any lab testing safeguards in place for consumers.
Federal reform forecast
Congress will narrow the farm bill loophole that has allowed hemp-derived cannabinoids to flood prohibition states.
The FDA will keep warning CBD sellers about false claims, but final FDA rules on CBD will not come out in 2023.
2023 will see no cannabis legalization bills pass Congress. Republicans take over control of the House, which means Republican committee chairs have the power to block any cannabis reform bills they don’t like—even if the bills have enough floor votes to pass.
The House has passed the MORE Act (which would end federal cannabis prohibition) twice in the past two years—but that winning streak will end in 2023 as Democrats hand over control of the chamber to Republicans. MORE Act co-sponsors will still have enough floor votes for House passage, but the measure won’t make it to the floor in 2023 if prohibitionist Republican committee chairs don’t like it. Kevin McCarthy (R-CA), the presumptive new Speaker of the House, will also prevent legalization measures from moving forward during his term. House Dems will block Republican-led pot reforms. We expect that the Senate won’t even have to weigh in.
In the US Senate, Democrats will still control the agenda—and they still won’t have enough votes to pass a legalization bill. Stodgy Democrats like Sen. Jeanne Shaheen (D-NH) will balk at an issue they don’t understand and refuse to consider. Federal THC potency limits will be discussed but not enacted.
Sen. John Fetterman (D-PA) will be both an outspoken champion for legalization in the US Senate, and will also work behind the scenes, having personal conversations with his peers in the Senate, about the need for legalization.
Congress will pass a small, incremental cannabis bill. Not SAFE Banking or MORE, but another bill cutting red tape around research.
Re-scheduling will be reviewed by the US DOJ but not decided on. There will be hearings.
State legalization predictions
Two states will try to do interstate commerce, but the actual legal weight moving between borders will be zero. The headlines will be great, though.
More Dormant Commerce Clause suits will happen, but rulings will be narrow. They might sever some aspects of the Controlled Substances Act, but they won’t topple it.
Oklahoma voters will pass adult-use legalization in a statewide March 7, 2023, election.
Minnesota state legislators will pass an adult-use legalization bill after months of wrangling over the details.
In Hawaii, state legislators will finally pass a full adult-use legalization bill, with new Gov. Josh Green (D) ready to sign it.
New Hampshire state legislators will make progress in gaining votes for a full adult-use legalization bill, but Gov. Chris Sununu (R) remains adamantly opposed to the idea. Without Sununu on board—and promising to veto any measure that passes—state legislators will improve on past bills, but will not make the effort to pass it this year. That’ll have to wait until Sununu moves on.
More states will enact expungement and/or resentencing for past marijuana offenses.
Drug testing rules will relax in newly legal states.
There will be more class action lawsuits around THC potency inflation—they’re very appetizing to lawyers who like to write press releases. But they won’t hold up in court because lab standards are so variable. California will enact nation-leading lab testing standards through regulatory review.
Source: David Downs and Bruce Barcott – leafly.com
